Powered by

FierceBiotech Executive Summit: Brexit remains a major concern for UK pharma

Nov 06, 2018 - Marketline Newswire

Post-Brexit UK medicines regulations have been a major talking point for the healthcare industry for over two years. With no agreement having yet been reached between the UK and EU on whether the UK will maintain or sever its ties with the European Medicines Agency (EMA), the healthcare industry is still grappling with what to expect from, and how to prepare for, the UK's departure from the EU on March 29, 2019.

This issue was a major talking point at the FierceBiotech Executive Summit 201...